Funder: National Institutes of Health (NIH)
Due Dates: November 25, 2025 (Full application)
Funding Amounts: ~$3,000,000 total for FY 2026, up to 4 awards; budgets not limited but must reflect project needs; max project period 5 years
Summary: Supports clinical trials to optimize evidence-based non-stimulant, psychosocial, and device-based treatment strategies for adult ADHD where stimulant monotherapy is insufficient, undesirable, or unavailable.
Key Information: Clinical trial required; only applications proposing studies in adults (18+) with DSM-5-TR ADHD are eligible.